Ortivus (ORTI B.ST) Stock Price

Ortivus Price

OMX·CLOSED
1.50
​
Market closed

Revenue at Ortivus has contracted by 5.1% per year over the past 19 years to 73.40 M SEK. Earnings per share have grown at 7.0% per year over the last 10 years. For Ortivus, the net margin of -29.8% is down versus 9.8% a few years ago.

Ortivus stock price

Access this data via the Eulerpool API

Ortivus business model & stock analysis

Ortivus AB engages in the development and sale of clinical devices and systems. The company is headquartered in Danderyd, Stockholm. The firm is engaged in the development of mobile surveillance and communication solutions, forming a decision support system. Its offering comprises: MobiMed Smart, a decision support system, which allows ambulance personnel to handle documentation, monitoring and introduce a structured approach in prehospital care; CoroNet, a mobile surveillance solution which allows patients to move freely under supervision of medical staff and provides healthcare professionals with monitoring information. In addition, the Company provides a wide range of services, such as support, implementation, training and consulting, among others. The Company’s customer base includes mainly ambulance services and emergency departments.

Frequently asked questions about Ortivus

Converted at the current exchange rate, the Ortivus share trades at 0.13 EUR (1.50 SEK).

The Ortivus share (ORTI B.ST) is listed on 3 stock exchanges, including: London (0H1Q.L), Stockholm (ORTI B.ST).

The revenue cannot currently be calculated for Ortivus.

The profit cannot currently be calculated for Ortivus.

The P/E ratio cannot be calculated for Ortivus at the moment.

The P/S cannot be calculated for Ortivus currently.

The Eulerpool Quality Score for Ortivus is 1/10.

The ISIN of Ortivus is SE0000123085. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Ortivus is ORTI B.ST. The ticker symbol is used to trade Ortivus shares on the stock exchange.

Fair ValueTerminal
1.30 SEK
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Technology
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website ortivus.com
Country
Sweden
Currency
SEK
Initial public offering
Jan 2, 1997
ISIN
SE0000123085
Cusip
W5612M105
Market capitalization
129.99 M SEKMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
5.80
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-52.16 %
Last updated Oct 11, 2026, 12:10 AM

Ortivus Peer Group

Ortivus Ticker

LONDON · 0H1Q.LSTOCKHOLM · ORTI-B.STSTOCKHOLM · ORTI B.ST

Ortivus FIGI

ORTIB:EO · BBG000QWJVZ3ORTIB:SS · BBG000J7SLF0ORTIB:XH · BBG000QWJX89ORTIB:XC · BBG000QWJXJ7ORTIB:XF · BBG000QWJXN2ORTIB:XE · BBG000QWJYH7ORTIB:XJ · BBG000QWJZ48ORTIB:XL · BBG000QWJZB0ORTIB:XG · BBG000QWK0N2ORTIB:XO · BBG000QWK0V3ORTIB:XS · BBG000QWK267ORTIB:XA · BBG000QWK2Q5

All fundamentals and in-depth analysis of Ortivus

Our stock analysis for Ortivus stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Ortivus. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.